February 17, 2016 - The court approved the settlement, the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice.
November 9, 2015 - The court preliminarily approved the settlement.

September 14, 2015 - Parties filed a stipulation of settlement.

December 31, 2013 - The court denied the defendants' motion to dismiss.

June 17, 2013 - The U.S. Court of Appeals for the First Circuit entered a formal mandate of the May 24, 2013 judgment.

May 24, 2013 - The U.S. Court of Appeals for the First Circuit entered a judgment that the district court's dismissal of the complaint is vacated and the matter is remanded for further proceedings.

July 19, 2012 - The lead plaintiffs filed a notice of appeal.

June 18, 2012 - The court granted defendants' motion to dismiss.

March 22, 2011 - The court denied defendants’ motion to dismiss without prejudice.

July 2, 2010 - Defendants filed a motion to dismiss.

June 1, 2010 - The lead plaintiffs filed a corrected amended consolidated complaint.

May 3, 2010 - The lead plaintiffs filed an amended consolidated complaint.

March 1, 2010 - Lead plaintiffs and lead counsels were appointed.

January 19, 2010 - Lead plaintiff motions were filed.

November 17, 2009 - An investor in shares of CVS Corporation (NYSE: CVS) filed a lawsuit in the U.S. District Court for the District of Rhode Island against CVS Corporation over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between May 5, 2009 and November 4, 2009.

According to the complaint the plaintiff alleges that CVS Corporation and certain of its officers and directors violated the Securities Exchange Act of 1934 by issuing between May 5, 2009 and November 4, 2009 numerous positive statements regarding CVS Corporation’s financial condition, business and prospects and failing to disclose operating problems in the PBM business, the more than $6 billion in contractual losses for 2010 and the adverse impact this would have on its 2010 financial results.

According to the complaint, CVS Corporation disclosed that the Federal Trade Commission (“FTC”) had begun a “nonpublic investigation” in August 2009 into whether CVS Corporation’s business practices and service offerings violated antitrust laws. Among the business practices of CVS Corporation that the FTC is reportedly investigating is the improper use of pricing and patient data from its retail pharmacy operations to steer its PBM members to CVS Corporation stores, so the lawsuit. Then on November 5, 2009, CVS Corporation issued a press release announcing the disclosures of the adverse material facts concerning the PBM business and their adverse impact on CVS Corporation's financial results for 2010, and the FTC investigation. In response to this press release, the price of CVS Corporation (NYSE: CVS) common stock fell 20% to close at $28.87.

CVS Corporation, located in Woonsocket, RI, is a provider of prescriptions and related healthcare services in the United States. It is a pharmacy services company and drives value for its customers through its approximately 6,900 CVS/pharmacy and Longs Drug retail stores. CVS Corporation with a Market Cap of $42.94 billion reported in 2007 Total Revenue of $76.3295 billion with a Net Income of $2.637 billion and in 2008 Total Revenue of $87.4719 billion with a Net Income of $3.2121 billion. Shares of CVS Corporation (NYSE: CVS) traded recently at $30.44 per share, down from its 52 week High of $38.27 per share and over $43 per share in 2008.